GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

The global Diabetic Retinopathy Market is valued at USD 9.1 Billion in 2024 and is projected to reach a value of USD 15.1 ...

Nearly 1 in 9 adults are living with diabetes, according to new research by the International Diabetes Federation.

The report by Apollo Hospitals zeroes in on three urgent health issues: fatty liver disease, post-menopausal health decline, ...

More than 36 million Americans have type 2 diabetes, meaning their blood sugar levels are always top of mind. After all, when ...

Globally, nearly one in nine adults (589 million) are now living with diabetes. Of these, an estimated 252 million are not yet aware they have the condition, placing them at higher risk of serious ...

The keto diet is a potentially helpful way for people with diabetes to manage blood sugar levels. This diet greatly restricts carbohydrates, which impact blood sugar. It may also aid in the reversal ...

People who might be considered thin or skinny can develop prediabetes, type 2, and gestational diabetes. Weight is one possible risk factor, including age, family medical history, and ethnicity.

Blood sugar was once considered something people only focused on when they had diabetes. But the explosion in popularity of medications that affect blood sugar, like Ozempic and Wegovy, along with ...

American pharmaceutical major Eli Lilly and Company on Thursday (March 20, 2025) launched its diabetes and obesity ... government and industry to promote awareness and improve the prevention ...

Type 2 diabetes causes a person’s blood sugar levels to become too high. Early signs of type 2 diabetes include increased thirst, frequent urination, and tiredness. Type 2 diabetes is a common ...

Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the ... and industry to promote awareness and improve the ...